It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Since the beginning of the covid-vaccine campaign, a lot of local and systemic dermatologic reactions happening after the administration of Corovirus disease 2019 (COVID-19) vaccines have been described, even if their exact biological mechanism is still debated. In this paper, we report four cases of cutaneous manifestations that arose within ten days after the first dose of messenger R (mR)-based COVID-19 vaccition: one case of giant urticaria, one case of head and neck redness, and two cases of Erythema multiforme. In our experience, these reactions were mild and transient and all of them resolved, not recurring after the second dose, so these manifestations shouldn’t be considered as an absolute contraindication to the second dose of vaccine, that to date is fundamental.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer